WebSify
Follow us on
Mail
Print

India's Glenmark Pharma announces discovery of new monoclonal antibody

Source : REUTERS
Last Updated: Mon, Feb 04, 2013 09:54 hrs
Hamied, chairman and MD of Indian generic drugmaker Cipla, poses for picture in front of cabinet containing company's products before interview in Mumbai

Indian drugmaker Glenmark Pharmaceuticals said on Monday it has discovered a new molecule that can be used to treat diseases such as rheumatoid arthritis and inflammatory bowel disease.

The new molecule, named GBR 830, is an anti-OX40 monoclonal antibody, Glenmark said in a statement, adding that OX40 is responsible for some autoimmune diseases.

The company said it has initiated studies for an investigational new drug (IND) application to be filed with the U.S. Food and Drug Administration.



blog comments powered by Disqus
most popular on facebook
talking point on sify finance